Literature DB >> 24397840

JSH Guidelines for the Management of Hepatitis C Virus Infection: A 2014 Update for Genotype 1.

.   

Abstract

Entities:  

Year:  2014        PMID： 24397840     DOI： 10.1111/hepr.12272

Source DB:  PubMed          Journal:  Hepatol Res        ISSN： 1386-6346            Impact factor:   4.288


× No keyword cloud information.
  20 in total

1.  Biochemical responses to bezafibrate improve long-term outcome in asymptomatic patients with primary biliary cirrhosis refractory to UDCA.

Authors:  Atsushi Tanaka; Junko Hirohara; Yasuni Nakanuma; Hirohito Tsubouchi; Hajime Takikawa
Journal:  J Gastroenterol       Date:  2014-09-20       Impact factor: 7.527

2.  The impact of an inosine triphosphate pyrophosphatase genotype on bilirubin increase in chronic hepatitis C patients treated with simeprevir, pegylated interferon plus ribavirin.

Authors:  Yuki Tahata; Naoki Hiramatsu; Tsugiko Oze; Naoki Morishita; Naoki Harada; Ryoko Yamada; Takayuki Yakushijin; Eiji Mita; Hideki Hagiwara; Yukinori Yamada; Toshifumi Ito; Taizo Hijioka; Masami Inada; Kazuhiro Katayama; Shinji Tamura; Harumasa Yoshihara; Atsuo Inoue; Yasuharu Imai; Keiko Irishio; Michio Kato; Hayato Hikita; Ryotaro Sakamori; Takuya Miyagi; Yuichi Yoshida; Tomohide Tatsumi; Toshimitsu Hamasaki; Norio Hayashi; Tetsuo Takehara
Journal:  J Gastroenterol       Date:  2015-07-30       Impact factor: 7.527

3.  Daclatasvir/asunaprevir/beclabuvir fixed-dose combination in Japanese patients with HCV genotype 1 infection.

Authors:  Joji Toyota; Yoshiyasu Karino; Fumitaka Suzuki; Fusao Ikeda; Akio Ido; Katsuaki Tanaka; Koichi Takaguchi; Atsushi Naganuma; Eiichi Tomita; Kazuaki Chayama; Shigetoshi Fujiyama; Yukiko Inada; Hitoshi Yoshiji; Hideaki Watanabe; Hiroki Ishikawa; Wenhua Hu; Fiona McPhee; Misti Linaberry; Philip D Yin; Eugene Scott Swenson; Hiromitsu Kumada
Journal:  J Gastroenterol       Date:  2016-08-09       Impact factor: 7.527

4.  Changes of shear-wave velocity by interferon-based therapy in chronic hepatitis C.

Authors:  Keisuke Osakabe; Naohiro Ichino; Toru Nishikawa; Hiroko Sugiyama; Miho Kato; Ai Shibata; Wakana Asada; Naoto Kawabe; Senju Hashimoto; Michihito Murao; Takuji Nakano; Hiroaki Shimazaki; Toshiki Kan; Kazunori Nakaoka; Yuka Takagawa; Masashi Ohki; Takamitsu Kurashita; Tomoki Takamura; Kentaro Yoshioka
Journal:  World J Gastroenterol       Date:  2015-09-21       Impact factor: 5.742

5.  Importance of virological response in the early stage of telaprevir-based triple therapy for hepatitis C.

Authors:  Satoshi Hiramine; Norihiro Furusyo; Eiichi Ogawa; Makoto Nakamuta; Eiji Kajiwara; Hideyuki Nomura; Kazufumi Dohmen; Kazuhiro Takahashi; Takeaki Satoh; Koichi Azuma; Akira Kawano; Toshimasa Koyanagi; Kazuhiro Kotoh; Shinji Shimoda; Jun Hayashi
Journal:  World J Hepatol       Date:  2015-11-18

6.  Probable case of drug reaction with eosinophilia and systemic symptom syndrome due to combination therapy with daclatasvir and asunaprevir.

Authors:  Takayoshi Suga; Ken Sato; Yuichi Yamazaki; Tatsuya Ohyama; Norio Horiguchi; Satoru Kakizaki; Motoyasu Kusano; Masanobu Yamada
Journal:  World J Clin Cases       Date:  2015-12-16       Impact factor: 1.337

7.  Comparison of peg-interferon, ribavirin plus telaprevir vs simeprevir by propensity score matching.

Authors:  Hideki Fujii; Takeshi Nishimura; Atsushi Umemura; Taichiro Nishikawa; Kanji Yamaguchi; Michihisa Moriguchi; Yoshio Sumida; Hironori Mitsuyoshi; Chihiro Yokomizo; Saiyu Tanaka; Hiroki Ishikawa; Kenichi Nishioji; Hiroyuki Kimura; Shiro Takami; Yasuyuki Nagao; Takayuki Takeuchi; Toshihide Shima; Yoshihiko Sawa; Masahito Minami; Kohichiroh Yasui; Yoshito Itoh
Journal:  World J Hepatol       Date:  2015-12-08

8.  Three renal failure cases successfully treated with ombitasvir/paritaprevir/ritonavir for genotype 1b hepatitis C virus reinfection after liver transplantation.

Authors:  Noriaki Orita; Tetsuro Shimakami; Hajime Sunagozaka; Rika Horii; Kouki Nio; Tekeshi Terashima; Noriho Iida; Masaaki Kitahara; Hajime Takatori; Kazunori Kawaguchi; Kazuya Kitamura; Kuniaki Arai; Taro Yamashita; Yoshio Sakai; Tatsuya Yamashita; Eishiro Mizukoshi; Masao Honda; Shuichi Kaneko
Journal:  Clin J Gastroenterol       Date:  2018-07-11

9.  Successful natural interferon-β plus ribavirin therapy in a chronic hepatitis C patient after discontinuation of interferon-α treatment due to arrhythmia and interstitial pneumonia.

Authors:  Akira Sato; Masahiro Yamauchi; Takayuki Yamada; Reiko Kumano; Kayo Adachi; Toshiya Ishii; Mikihito Hayashi; Daisuke Kumon
Journal:  Clin J Gastroenterol       Date:  2014-06-06

10.  Daclatasvir plus asunaprevir for chronic HCV genotype 1b infection.

Authors:  Hiromitsu Kumada; Yoshiyuki Suzuki; Kenji Ikeda; Joji Toyota; Yoshiyasu Karino; Kazuaki Chayama; Yoshiiku Kawakami; Akio Ido; Kazuhide Yamamoto; Koichi Takaguchi; Namiki Izumi; Kazuhiko Koike; Tetsuo Takehara; Norifumi Kawada; Michio Sata; Hidetaka Miyagoshi; Timothy Eley; Fiona McPhee; Andrew Damokosh; Hiroki Ishikawa; Eric Hughes
Journal:  Hepatology       Date:  2014-04-01       Impact factor: 17.425
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.